Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions

Clin Vaccine Immunol. 2008 Jan;15(1):172-5. doi: 10.1128/CVI.00292-07. Epub 2007 Nov 7.

Abstract

The aim of this study was to develop a highly sensitive human papillomavirus type 31 (HPV31) neutralization assay based on the production of pseudovirions carrying luciferase. Neutralizing antibodies against HPV31 were investigated in a set of HPV31 monoclonal antibodies and in women with evidence of HPV31 infection. Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral / analysis*
  • Antibodies, Viral / immunology
  • COS Cells
  • Cell Line
  • Chlorocebus aethiops
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Humans
  • Insecta
  • Luciferases / biosynthesis
  • Luciferases / chemistry*
  • Luciferases / genetics
  • Neutralization Tests
  • Papillomaviridae / immunology*
  • Papillomaviridae / isolation & purification
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / immunology
  • Papillomavirus Infections / virology
  • Virion / enzymology*
  • Virion / genetics
  • Virus Assembly / physiology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Luciferases